We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
135 hedge funds and large institutions have $769M invested in Madrigal Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 54 increasing their positions, 32 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
69% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 32
1% less capital invested
Capital invested by funds: $780M → $769M (-$10.8M)
1.04% less ownership
Funds ownership: 70.21% → 69.17% (-1%)
2% less funds holding
Funds holding: 138 → 135 (-3)
10% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 20
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
39% less call options, than puts
Call options by funds: $19.2M | Put options by funds: $31.4M
Holders
135
Holders Change
-3
Holders Change %
-2.17%
% of All Funds
2.33%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
18
Increased
54
Reduced
32
Closed
20
Calls
$19.2M
Puts
$31.4M
Net Calls
-$12.2M
Net Calls Change
-$21.5M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$12M |
| 2 |
State Street
Boston,
Massachusetts
|
+$9.82M |
| 3 |
AC
Armistice Capital
New York
|
+$9.45M |
| 4 |
Goldman Sachs
New York
|
+$8.88M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$6.64M |
Top Sellers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$64.8M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$8.57M |
| 3 |
Jennison Associates
New York
|
-$4.79M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$4.45M |
| 5 |
PA
Perceptive Advisors
New York
|
-$2.53M |
